This federal contract award, SPE2DB22D1106|SPE2DB25FDXA2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,619.10 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S.
The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, a for-profit organization, is the prime contractor, and there is no mention of any major subcontractors. The DLA, a defense agency, is the funding agency for this award, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 5/4/25, 12:51 AM